Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04670822 · ClinicalTrials.gov registry record · NA

Postpartum Smoking Relapse Prevention by Breastfeeding Promotion

A NA study, sponsored by State University of New York at Buffalo.

Completed
Registry status
NA
Development phase
60
Enrollment target

NCT04670822 is a NA study that has completed, run by State University of New York at Buffalo. The registered enrollment target is 60 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04670822, a NA study, has completed, sponsored by State University of New York at Buffalo.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

This is a randomized controlled trial to prevent postpartum smoking relapse by breastfeeding promotion. The intervention group (N=30) will receive multicomponent breastfeeding intervention from late pregnancy to 6 months postpartum, while the attention placebo control group (N=30) will receive general infant care counseling and support. The key outcome is the rate of postpartum smoking relapse.

Interventions

  • BEHAVIORAL Breastfeeding promotion
  • BEHAVIORAL Attention placebo control

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2018-07-31
Est. Completion 2023-12-31
Phase NA

What the Registry Record Tells You About NCT04670822

The ClinicalTrials.gov registry entry for NCT04670822 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York at Buffalo, which has 243 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Breastfeeding promotion is the first listed.

NCT04670822 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04670822 about?

NCT04670822 is a clinical study titled "Postpartum Smoking Relapse Prevention by Breastfeeding Promotion". This is a randomized controlled trial to prevent postpartum smoking relapse by breastfeeding promotion. The intervention group (N=30) will receive multicomponent breastfeeding intervention from late pregnancy to 6 months postpartum, while the attention placebo control group (N=30) will receive gener...

What is the current status of trial NCT04670822?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2018-07-31. Estimated completion is 2023-12-31.

What interventions are being tested in trial NCT04670822?

The interventions under investigation include: Breastfeeding promotion (BEHAVIORAL), Attention placebo control (BEHAVIORAL).

Who is sponsoring clinical trial NCT04670822?

This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.